Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II). Integrilin to Minimize Platelet Aggregation and Coronary Thrombosis. [electronic resource]
Producer: 20000331Description: 427-34 p. digitalISSN:- 0002-9149
- Aged
- Angina, Unstable -- mortality
- Angioplasty, Balloon, Coronary -- adverse effects
- Coronary Thrombosis -- mortality
- Electrocardiography
- Eptifibatide
- Female
- Humans
- Infusions, Intravenous
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- Peptides -- administration & dosage
- Platelet Aggregation Inhibitors -- administration & dosage
- Prospective Studies
- Risk Factors
- Secondary Prevention
- Survival Rate
- Thrombolytic Therapy
- Time Factors
- Treatment Outcome
- United States -- epidemiology
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.